These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6686063)

  • 21. [Intensification of the effect of exogenous plasminogen activators on lysis of fibrin blood clots due to a decrease in the level of alpha-2- antiplasmin by a plasmasorption method].
    Ogloblina OG; Saburova OS; Semenova OA; Belova LA
    Biokhimiia; 1994 Jan; 59(1):62-8. PubMed ID: 7509643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro.
    Korninger C; Collen D
    Thromb Haemost; 1981 Aug; 46(2):561-5. PubMed ID: 6795744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of carboxypeptidase U (TAFIa) activity improves rt-PA induced thrombolysis in a dog model of coronary artery thrombosis.
    Björkman JA; Abrahamsson TI; Nerme VK; Mattsson CJ
    Thromb Res; 2005; 116(6):519-24. PubMed ID: 16181987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance of porcine blood clots to lysis relates to poor activation of porcine plasminogen by tissue plasminogen activator.
    Flight SM; Masci PP; Lavin MF; Gaffney PJ
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):417-20. PubMed ID: 16788320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of tissue-type plasminogen activator from a culture of calf kidney cells on hemostasis and fibrinolysis in experimental nephritis].
    Andreenko GV; Podorol'skaia LV; Serebriakova TN; Liaginskiĭ AV; Egorov BB
    Biull Eksp Biol Med; 1988 Oct; 106(10):424-6. PubMed ID: 3142531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of beta-sitosterol on the fibrinolytic potential in rabbits.
    Hoffmann A; Klöcking HP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):189-96. PubMed ID: 2459019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
    Collen D; Lijnen HR
    Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is exogenous tissue plasminogen activator necessary for antithrombotic efficacy of an inhibitor of thrombin activatable fibrinolysis inhibitor (TAFI) in rats?
    Bird E; Tamura J; Bostwick JS; Steinbacher TE; Stewart A; Liu Y; Baumann J; Feyen J; Tamasi J; Schumacher WA
    Thromb Res; 2007; 120(4):549-58. PubMed ID: 17229457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit.
    Marder VJ; Landskroner K; Novokhatny V; Zimmerman TP; Kong M; Kanouse JJ; Jesmok G
    Thromb Haemost; 2001 Sep; 86(3):739-45. PubMed ID: 11583303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fibrinolytic system of animals repeatedly and chronically administered plasminogen tissue activator].
    Shimonaeva EE; Liutova LV; Andreenko GV
    Vopr Med Khim; 1981; 27(6):823-8. PubMed ID: 7199779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multiparameter test of clot formation and fibrinolysis for in-vitro drug screening.
    Kostka B; Para J; Sikora J
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):611-8. PubMed ID: 17890947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrinolytic activity during orthotopic liver transplantation with and without aprotinin.
    Segal HC; Hunt BJ; Cottam S; Downing A; Beard C; Francis JL; Potter D; Tan KC
    Transplantation; 1994 Dec; 58(12):1356-60. PubMed ID: 7528949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha.
    Orbe J; Chordá C; Montes R; Páramo JA
    Haematologica; 1999 Apr; 84(4):306-11. PubMed ID: 10190943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human extrinsic plasminogen activator fibrinolytic properties and neutralization in vivo.
    Mattsson C; Nilsson S; Häggroth L
    Thromb Res; 1983 Apr; 30(1):91-100. PubMed ID: 6683005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Thrombolytic action of a heparin-ocrase complex].
    Liapina LA; Klöcking HP
    Farmakol Toksikol; 1978; 41(2):174-7. PubMed ID: 658360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of fibrinolytic and thrombolytic potential in the rat by treatment with an anabolic steroid, furazabol.
    Kumada T; Abiko Y
    Thromb Haemost; 1976 Nov; 36(2):451-64. PubMed ID: 1036845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethanol increases surface-localized fibrinolytic activity in cultured endothelial cells.
    Aikens ML; Benza RL; Grenett HE; Tabengwa EM; Davis GC; Demissie S; Booyse FM
    Alcohol Clin Exp Res; 1997 Nov; 21(8):1471-8. PubMed ID: 9394120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-thrombotic effect of a PAI-1 inhibitor in rats given endotoxin.
    Abrahamsson T; Nerme V; Strömqvist M; Akerblom B; Legnehed A; Pettersson K; Westin Eriksson A
    Thromb Haemost; 1996 Jan; 75(1):118-26. PubMed ID: 8713790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A thrombosis model for evaluating thrombolytic agents in the guinea-pig: comparison of t-PA, scu-PA and a novel thrombolytic agent, staphylokinase, on thrombolytic activity.
    Hirata Y; Umemura K; Takiguchi Y; Uematsu T; Nakashima M
    Blood Coagul Fibrinolysis; 1993 Aug; 4(4):569-75. PubMed ID: 7692999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extraction of plasminogen activator in the rat's submaxillary gland.
    Lucas ON; Lucas GV
    Acta Physiol Pharmacol Ther Latinoam; 1995; 45(2):115-22. PubMed ID: 8580523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.